Search

everythinglearnresearchcommunity

for

Search:↓

The document lists various dermatology topics, treatments, and diagnostic methods.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Androgenetic alopecia is a common hair thinning condition linked to genetics and hormones.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

Isotretinoin was not effective in treating facial lichen planopilaris.

Hair follicle bumps with stem cells might contribute to permanent hair loss by getting disconnected due to scarring.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

The patient responded well to treatment with no disease progression.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Men with lichen planopilaris had earlier onset than women, and treatment usually improved the condition.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Hydroxychloroquine is ineffective for treating frontal fibrosing alopecia with lupus erythematosus.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Frontal fibrosing alopecia can mimic traction alopecia but has distinct features like facial papules and eyebrow thinning.

Elastin staining helps assess late-stage scarring alopecia but is not definitive, and clinical diagnosis is still crucial.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Light-based therapies show promise as safe treatments for hair loss.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

The best treatment for lichen planopilaris is a combination of clobetasol, hydroxychloroquine, and N-acetylcysteine.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.